SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003736
Filing Date
2023-02-07
Accepted
2023-02-06 17:35:19
Documents
12
Period of Report
2023-02-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37593
  Complete submission text file 0001493152-23-003736.txt   211221

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT shph-20230206_lab.xml EX-101.LAB 34240
3 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT shph-20230206_pre.xml EX-101.PRE 22369
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT shph-20230206.xsd EX-101.SCH 3242
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3625
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 23591730
SIC: 2834 Pharmaceutical Preparations